Collateral for a security interest recorded Apr 8, 2026 (Royal Bank of Canada).
Term ended Sep 1, 2026 · High confidence
20-year base term ended Feb 2, 2026
Held by Gynesonics, Inc.
Filed Dec 14, 2018 as application 16/221,138 · Granted Aug 23, 2022
Base term plus 211 days of patent term adjustment (USPTO delay)
Today
Term ended Sep 1, 2026
2006
2026
Clock starts
Feb 2, 2006
Feb 2, 2006
Term ended
Sep 1, 2026
Sep 1, 2026
Granted
Aug 23, 2022
Aug 23, 2022
base term
patent term adjustment
after the term ends
fee events
Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
211
Days of term adjustment
Read from the USPTO patent term adjustment record, not recalculated here.
No effect
Terminal disclaimer
Resolved from the filed document, referencing US 7,918,795, to Sep 1, 2026. The term already ends on or before that date, so the cap shortened nothing.
1 of 1
Maintenance fees paid
One maintenance fee can end this term early, the one due 3.5 years from grant; the next one's grace period runs past the term end. This counts it if the record shows it paid.
7
Family applications on record here
Applications sharing this one's continuity chain whose file history this site holds. The family may have others.
This patent's term runs 211 days past its 20-year base term on prosecution delay. A terminal disclaimer is resolved from the filed document, and it ends no earlier than this term, so it shortens nothing. Confidence: High. from the record
How we calculated this date
One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts Feb 2, 2006, when application 11/347,018, the earliest non-provisional in its chain, was filed (this one was filed Dec 14, 2018) | Feb 2, 2026 | High confidence |
| Continuity chain | Every parent in the chain resolved | no change | High confidence |
| Patent term adjustment | +211 days, USPTO patent term adjustment record | Sep 1, 2026 | High confidence |
| Terminal disclaimer cap | Disclaimer resolved from the filed document (refs US 7,918,795) | resolves to Sep 1, 2026, no earlier than this term, so no change | High confidence |
| Patent term extension | None on file | no change | High confidence |
| Fee events | 1 of 1 maintenance fees paid | term ended | High confidence |
| Computed term end | The steps above, in order | Sep 1, 2026 | High confidence |
This family
| US 7,918,795 | In force Mar 2028 | Mar 2028 |
| US 9,808,310 | Term ended no later than Nov 2026 | no later than Nov 2026 |
| US 9,987,080 | Term ended Feb 2026 | Feb 2026 |
| US 10,182,862 | Term ended Feb 2026 | Feb 2026 |
| US 11,419,668 | this patent Sep 2026 | Sep 2026 |
| US 11,950,837 | Term ended Feb 2026 | Feb 2026 |
| US 12,414,813 | Term ended Feb 2026 | Feb 2026 |
The applications whose file history this site holds. The family may have others.
Assignments
Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
| Recorded | Assignor | Assignee | Conveyance |
|---|---|---|---|
| Dec 14, 2018 Reel 47784, frame 360 | Grossman, Jessica | Gynesonics, Inc. | Assignment of Assignor's Interest |
| Feb 14, 2025 Reel 70236, frame 154 | Gynesonics, Inc. | Bank of America, N.A., as Collateral Agent | Security Interest |
| Apr 8, 2026 Reel 75462, frame 440 | Biotheranostics, Inc.; Gen-Probe Incorporated; Gen-Probe Prodesse, Inc.; Cytyc Corporation; Suros Surgical Systems, Inc.; Gynesonics, Inc.; Bolder Surgical, LLC; Faxitron Bioptics, LLC; Health Beacons, Inc.; Hologic, Inc. | Royal Bank of Canada, as Collateral Agent | Security Interest |
| Apr 8, 2026 Reel 75926, frame 339 | Biotheranostics, Inc.; Gen-Probe Incorporated; Gen-Probe Prodesse, Inc.; Cytyc Corporation; Suros Surgical Systems, Inc.; Gynesonics, Inc.; Bolder Surgical, LLC; Faxitron Bioptics, LLC; Health Beacons, Inc.; Hologic, Inc. | Citibank, N.A., as Collateral Agent | Security Interest |
| Apr 24, 2026 Reel 75455, frame 789 | Bank of America, N.A., as Collateral Agent | Gynesonics, Inc. | Release of Security Interest Recorded at Reel/Frame 070236/0154 |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
What's changing
Note
The 211 days of patent term adjustment (USPTO delay) are read from the USPTO record, not recalculated by us
Terminal disclaimer
A terminal disclaimer resolved from the filed document, referencing US 7,918,795, ends no earlier than this term, so it caps nothing.
Citations
11
later US patents cite this one
That is top 10% of utility patents granted in 2022 in our data, the only group it is compared against.
How we rank
Every date shows its work: the base term, any term adjustment or extension, any disclaimer cap, and the maintenance fee record, each with a confidence tier. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.